20Th Bioasia Forum To Promote Msmes In Life Science And Heal...| MENAFN.COM

Monday, 06 February 2023 02:45 GMT

20Th Bioasia Forum To Promote Msmes In Life Science And Health Tech

(MENAFN- KNN India) 20th BioAsia Forum to promote MSMEs in life science and health tech

Hyderabad, Dec 9 (KNN)
Department of Micro Small and Medium Enterprises (MSME)
has partnered with BioAsia
to promote the MSME sector for the 20th edition of the event on life-sciences and health tech.

is regarded as Asia's largest life-sciences and health tech forum
and the annual flagship event of the Government of Telangana.

It will be held from February 24 to 26, 2023 in Hyderabad
and will bring together delegates, leaders, entrepreneurs, and professionals from the life science and healthcare sector from the global arena.

Emphasising on the partnership, D. Chandra Sekhar, Additional Development Commissioner, MSME-DI, Hyderabad
said,“and global opportunities into the life sciences. With this collaboration and participation in BioAsia 2023, we trust the MSME players will be immensely benefitted from its gained significant stature in healthcare industries across the globe.”

Association with the Department of MSME is likely to foster MSME growth.

It will give a boost to MSME organisations that play a significant role in strengthening the position of India in the global life sciences industry.

A dedicated
MSME Pavilion
has been proposed to be installed in the tradeshow with around
60 companies from the MSME
sector covering Medical Devices, Pharmaceuticals, and allied industries.

Through the Procurement & Market Support (PMS) – Market Access Initiatives of Di-MSME, the cost of participation for MSMEs are being subsidized upto 100%.
(KNN Bureau)


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.